Publication: New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies
| dc.contributor.author | Paris, Juan L. | |
| dc.contributor.author | de la Torre, Paz | |
| dc.contributor.author | Flores, Ana I. | |
| dc.contributor.authoraffiliation | [Paris,JL] Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Paris,JL] Andalusian Centre for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain. [de la Torre,P; Flores,AI] Grupo de Medicina Regenerativa, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. | |
| dc.date.accessioned | 2024-02-19T15:32:22Z | |
| dc.date.available | 2024-02-19T15:32:22Z | |
| dc.date.issued | 2021-12-14 | |
| dc.description.abstract | Allergy constitutes a major health issue due to its large prevalence. The established therapeutic approaches (allergen avoidance, antihistamines, and corticosteroids) do not address the underlying causes of the pathology, highlighting the need for other long-term treatment options. Antigen-specific immunotherapy enables the long-term control of allergic diseases by promoting immunological tolerance to the allergen. However, efficacious immunotherapies are not available for all possible allergens, and the risk of undesired reactions during therapy remains a concern, especially in patients with severe allergic reactions. In this context, two types of therapeutic strategies appear especially promising for the future in the context of allergy: cell therapy and bio- or nano-material-based therapy. In this review, the main strategies developed this far in these two types of strategies are discussed, with several examples illustrating the different approaches. | |
| dc.description.sponsorship | This work was funded by Instituto de Salud Carlos III (ISCIII), Ministry of Economy, Industry, and Competitiveness, co-funded by the European Regional Development Fund, grants number PI18/01278; and PI 20/012 by Fundacion Francisco Soria Melguizo. J.L.P holds a “Sara Borrell” fellowship (CD19/00250) from ISCIII, co-funded by the European Social Fund (“El FSE invierte en futuro”). | |
| dc.identifier.doi | 10.3390/pharmaceutics13122149 | |
| dc.identifier.e-issn | 1999-4923 | es_ES |
| dc.identifier.journal | Pharmaceutics | es_ES |
| dc.identifier.other | http://hdl.handle.net/10668/4125 | |
| dc.identifier.pubmedID | 34959429 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/18519 | |
| dc.language.iso | eng | |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | |
| dc.relation.publisherversion | https://www.mdpi.com/1999-4923/13/12/2149 | es |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Allergy | |
| dc.subject | Cell therapy | |
| dc.subject | Biomaterials | |
| dc.subject | Nano-materials | |
| dc.subject | Immunotherapy | |
| dc.subject | Alergia e inmunología | |
| dc.subject | Tratamiento basado en trasplante de células y tejidos | |
| dc.subject | Materiales biocompatibles | |
| dc.subject | Nanoestructuras | |
| dc.subject | Inmunoterapia | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Prevalence | |
| dc.subject.mesh | Allergens | |
| dc.subject.mesh | Adrenal Cortex Hormones | |
| dc.subject.mesh | Histamine Antagonists | |
| dc.title | New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies | |
| dc.type | review article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isPublisherOfPublication | 30293a55-0e53-431f-ae8c-14ab01127be9 | |
| relation.isPublisherOfPublication.latestForDiscovery | 30293a55-0e53-431f-ae8c-14ab01127be9 |


